Filing Details
- Accession Number:
- 0001181431-13-019223
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-27 20:14:22
- Reporting Period:
- 2013-03-25
- Filing Date:
- 2013-03-27
- Accepted Time:
- 2013-03-27 20:14:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1428044 | Excel Medical Fund Lp | 800 Boylston St. Suite 2825 Boston MA 02199 | No | No | Yes | No | |
1571999 | Excel Medical Ventures, Llc | 800 Boylston St. Suite 2825 Boston MA 02199 | No | No | Yes | No | |
1572066 | R. Frederick Blume | 800 Boylston St. Suite 2825 Boston MA 02199 | No | No | Yes | No | |
1572090 | Juan Enriquez | 800 Boylston St. Suite 2825 Boston MA 02199 | No | No | Yes | No | |
1572197 | Enrico Petrillo | 800 Boylston St. Suite 2825 Boston MA 02199 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-25 | 972,384 | $0.00 | 972,384 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2013-03-25 | 496,121 | $7.00 | 1,468,505 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 28,199,144 | $0.00 | 972,384 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
- Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P., Frederick R. Blume, Juan Enriquez and Enrico Petrillo are Managing Directors of Excel Medical Ventures, LLC. Excel Medical Ventures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- Not Applicable